Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2019
Operating activities:
Net income (loss)	$ 8,612	$ (68,463)	$ 1,311
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	30,672	30,827	28,797
Amortization of debt discount and deferred financing costs	13,797	13,200	19,759
Amortization of right-of-use asset	48,480	45,649
Accretion of notes receivable discount and deferred compensation fee	0	(821)	(4,524)
Deferred income taxes	3,283	(8,393)	1,616
Impairment of goodwill, intangibles and other assets	0	54,666	0
Other adjustments	(185)	1,652	5,776
Provision for inventory reserve	(8,003)	2,577	536
Reserve on jewelry scrap receivable	0	0	3,646
Stock compensation expense	3,946	(5,094)	9,751
Equity in net (income) loss from investment in unconsolidated affiliates	(3,803)	2,429	135
Impairment of investment in unconsolidated affiliates	0	0	19,725
Changes in operating assets and liabilities, net of business acquisitions:
Service charges and fees receivable	(7,332)	11,021	(732)
Inventory	371	14,466	(1,029)
Prepaid expenses, other current assets and other assets	7,373	(875)	5,732
Accounts payable, accrued expenses and other liabilities	(54,209)	(37,401)	22,246
Customer layaway deposits	1,256	(1,647)	1,176
Income taxes	2,180	(4,715)	(10,404)
Net cash provided by operating activities	46,438	49,078	103,517
Investing activities:
Loans made	(601,638)	(568,368)	(737,585)
Loans repaid	351,092	394,469	434,142
Recovery of pawn loan principal through sale of forfeited collateral	208,551	304,323	288,502
Capital expenditures, net	(23,601)	(28,526)	(38,839)
Acquisitions, net of cash acquired	(19,015)	0	(8,116)
Principal collections on notes receivable	0	8,000	34,067
Net cash (used in) provided by investing activities	(84,611)	109,898	(27,829)
Financing activities:
Taxes paid related to net share settlement of equity awards	(839)	(1,459)	(3,288)
Payout of deferred consideration	0	(350)	0
Proceeds from borrowings, net of issuance costs	0	912	1,064
Payments on assumed debt and other borrowings	(15,414)	(198)	(196,093)
Repurchase of common stock	0	(5,158)	0
Net cash used in financing activities	(16,253)	(6,253)	(198,317)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	5,497	(2,612)	(507)
Net (decrease) increase in cash and cash equivalents and restricted cash	(48,929)	150,111	(123,136)
Cash and cash equivalents and restricted cash at beginning of period	312,553	162,442	285,578
Cash and cash equivalents and restricted cash at end of period	263,624	312,553	162,442
Supplemental disclosure of cash flow information
Cash and cash equivalents	253,667	304,542	157,567
Restricted cash	9,957	8,011	4,875
Total cash and cash equivalents and restricted cash	263,624	312,553	162,442
Cash paid during the period for interest	8,230	8,489	12,900
Cash paid during the period for income taxes, net	3,696	9,753	11,132
Non-cash investing and financing activities:
Pawn loans forfeited and transferred to inventory	212,756	241,252	301,357
Transfer of consideration for current period acquisition	1,545	0	0
Acquisition earn-out contingency	4,608	0	0
Accrued acquisition consideration held as restricted cash	$ 1,986	$ 0	$ 0